Results 31 to 40 of about 495 (168)

Protein deficiency impairs the schistosomicidal action of praziquantel [PDF]

open access: yesMemórias do Instituto Oswaldo Cruz, 1998
The synergism between schistosomicidal drugs and the host immune system has been currently described in the literature. Antimonium and potassium tartarate, oxamniquine and praziquantel [PZQ are not as effective in immunocompromised hosts as it is in normal ones].
S. F. Lima   +3 more
openaire   +3 more sources

Guidelines for the diagnosis and treatment of schistosomal myeloradiculopathy Orientações sobre o diagnóstico e tratamento da mielorradiculopatia associada à esquistossomose

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2007
Schistosomal myeloradiculopathy is the most severe and disabling ectopic form of Schistosoma mansoni infection. The prevalence of SMR in centres in Brazil and Africa that specialise in attending patients with non traumatic myelopathy is around 5%.
José Roberto Lambertucci   +2 more
doaj   +1 more source

PROTOCOL: Mass deworming for improving health and cognition of children in endemic helminth areas: a systematic review and individual participant data network meta‐analysis

open access: yes, 2018
Campbell Systematic Reviews, Volume 14, Issue 1, Page 1-46, 2018.
Vivian Welch   +15 more
wiley   +1 more source

PROTOCOL: Interventions for improving learning outcomes and access to education in low‐ and middle‐income countries: a systematic review

open access: yes, 2017
Campbell Systematic Reviews, Volume 13, Issue 1, Page 1-82, 2017.
Birte Snilstveit   +8 more
wiley   +1 more source

PROTOCOL: Deworming and adjuvant interventions for improving the developmental health and well‐being of children in low‐and middle‐income countries: a systematic review and network meta‐analysis

open access: yes, 2013
Campbell Systematic Reviews, Volume 9, Issue 1, Page 1-41, 2013.
Vivian Welch   +9 more
wiley   +1 more source

Editorial: Pre-Conference Research Topic: 16th International Symposium on Schistosomiasis

open access: yesFrontiers in Immunology, 2021
Cristina Toscano Fonseca   +4 more
doaj   +1 more source

Estudo de uma cepa humana de Schistosoma mansoni resistente a agentes esquistossomicidas

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 1973
Foi isolada uma cepa de Schistosoma mansoni proveniente de dois pacientes tratados com hycanthone, por duas vezes, na dose de 2,5mg/kg, i.m., em janeiro e em abril de 1970, e com niridazole (25mg/kg dia x 5 oral), em abril de 1971.
Naftale Katz   +3 more
doaj  

Schistosoma mansoni: In vitro schistosomicidal activity of piplartine

open access: yesExperimental Parasitology, 2011
Schistosomiasis is one of the world's greatly neglected tropical diseases, and its control is largely dependent on a single drug, praziquantel. Here, we report the in vitro effect of piplartine, an amide isolated from Piper tuberculatum (Piperaceae), on Schistosoma mansoni adult worms. A piplartine concentration of 15.8 μM reduced the motor activity of
Josué de, Moraes   +6 more
openaire   +2 more sources

Prevalence of Schistosoma Haematobium Amongst Secondary School Children in Ovia North East Local Government Area, Edo State.

open access: yesSokoto Journal of Medical Laboratory Science, 2018
Schistosomiasis is a disease caused by infection with parasitic blood flukes. It is also known as bilhaarziasis. Schistosomiasis has been a menace or scourge of ages causing global health challenges in the practice of medicine. Schistosoma haematobium is
Okungbowa, M.A.O.* and Adeyemi, E.
doaj  

Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial

open access: yesBulletin of the World Health Organization, 2003
OBJECTIVE: To evaluate the therapeutic efficacy of oxamniquine and praziquantel, the two most clinically important schistosomicide drugs, and to compare the accuracy of faecal examination with the accuracy of oogram in testing for Schistosoma mansoni ...
Ferrari M.L.A.   +4 more
doaj  

Home - About - Disclaimer - Privacy